US SB844 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 14 2019 - 25% progression, died in committee
Action: 2019-03-14 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 14 2019 - 25% progression, died in committee
Action: 2019-03-14 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to allow for expedited approval of generic prescription drugs and temporary importation of prescription drugs in the case of marginally competitive drug markets and drug shortages.
Title
Short on Competition Act
Sponsors
| Sen. Amy Klobuchar [D-MN] | Sen. Mike Lee [R-UT] | Sen. Richard Durbin [D-IL] | Sen. Chuck Grassley [R-IA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-03-14 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
Congressional oversight
Drug safety, medical device, and laboratory regulation
Health
Prescription drugs
Trade restrictions
Drug safety, medical device, and laboratory regulation
Health
Prescription drugs
Trade restrictions
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/844/all-info |
| Text | https://www.congress.gov/116/bills/s844/BILLS-116s844is.pdf |
